Floragraph to present at the 3rd Annual North America Microbiome Congress on February 5, 2018

San Jose, January 29, 2018 – Floragraph, Inc., is pleased to announce that founder and CEO Alicia Scheffer-Wong will be a featured presenter at the 3rd Annual North America Microbiome Congress, to be held February 5–7 at the Hilton San Diego Resort.

Date: Monday, February 5, 2018
Time: 3:20PM (PST)
Session: Innovation Stage
Venue: Hilton San Diego Resort & Spa, 1775 East Mission Bay Drive, San Diego, CA 92019

Scheffer-Wong has been invited to discuss Floragraph’s revolutionary infant microbiome monitoring platform on the “Innovation Stage”, in front of a panel of expert investors, consultants, pharmaceutical companies, successful start-ups, and lawyers. Floragraph’s novel microfluidic sample preparation methodology and innovative microarray measurement technology will be presented, as will plans for development and commercialization.

The 3rd Annual North America Microbiome Congress in San Diego, by Kisaco Research, has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require an insight into the latest microbiome research, clinical trials and collaborative partnerships.

About Floragraph:

Floragraph is a seed-stage startup developing the first at-home microbiome monitoring device, going from “poop to profile” in 3 hours, at low cost, in the comfort of your home. The development of a healthy microbiome over the first year of life is critical to long term health and perturbations to this process, including C-sections, antibiotic use, and lack of breastfeeding, can lead to numerous long-term health conditions, such as asthma, autoimmune disease, and obesity. Floragraph’s solution provides parents a quantitative measure of their baby’s developing microbiome, enabling healthy choices that last a lifetime.

Floragraph, Inc.
1821 S. Bascom Ave. #207
Campbell, CA 95008 

Alicia Scheffer-Wong, Founder & CEO